Going Off Script: An Update on Clinical Guidelines, Novel, Repurposed and Adjunct Drugs in the Treatment of Adults with Bipolar Disorder

Authors

Todd B. Bernsohn, University of LynchburgFollow

Specialty

Psychiatry

Advisor

Dr. Trey Boyd, DMSc, PA-C

Abstract

ABSTRACT

Bipolar Disorder (BD) is a common diagnosis in behavioral/mental health practice, and despite a multifaceted approach to management: pharmacotherapy, psychotherapeutic, family and lifestyle interventions, electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), etc., management remains complex and unsatisfactory.Repurposing drugs for treatment is one of many promising approaches to this problem, and it is vital that providers remain current on novel, trial and evidence-based data in order to utilize optimal management strategies. Advanced practice providers (APPs) and physicians who work in behavioral medicine, primary/family medicine, internal medicine, emergency medicine, hospitalists and pharmacists will benefit from this article. Adults with BD and their families or caretakers may utilize this information as well. Guidelines and clinical practices as to the pharmacological treatment for BD are ever changing, as novel and repurposed drugs are approved for use or utilized for off-label management of this complex disorder. This article will aid providers in staying current on options and recommendations for optimal treatment.

Recommended Citation

Bernsohn TB. Going Off Script: An Update on Clinical Guidelines, Novel, Repurposed and Adjunct Drugs in the Treatment of Adults with Bipolar Disorder. University of Lynchburg DMSc Doctoral Project Assignment Repository. 2022; 4(3).